Challenges of measuring outcomes in ‘real-life’ DM programmes Carlene Todd Newsletter Article 09 February 2013 Pages: 3 - 4
Antibacterials best available option for GBS infection in neonates Newsletter Article 09 February 2013 Pages: 5 - 5
Prednicarbate preferable to fluocortin in inflammatory dermatoses Newsletter Article 09 February 2013 Pages: 5 - 5
First study of the US costs of occupation-related illnesses Newsletter Article 09 February 2013 Pages: 6 - 6
Direct healthcare consumption drives cost of CVD in The Netherlands Newsletter Article 09 February 2013 Pages: 6 - 6
Risperidone cost effective for improving QOL in schizophrenia Newsletter Article 09 February 2013 Pages: 7 - 7
Model a useful guide to therapy for meningococcal disease Newsletter Article 09 February 2013 Pages: 7 - 7
Cost effectiveness of postexposure HIV prophylaxis Newsletter Article 09 February 2013 Pages: 10 - 10